AMENDMENT TO THE RECAPITALIZATION AGREEMENTThe Recapitalization Agreement • November 6th, 2006 • Corautus Genetics Inc • Biological products, (no disgnostic substances)
THIS AMENDMENT TO THE RECAPITALIZATION AGREEMENT (“Amendment”) made as of the 31st day of October, 2006, by and between CORAUTUS GENETICS INC., a Delaware corporation (the “Company”) and BOSTON SCIENTIFIC CORPORATION, a Delaware corporation (“Exchangor”).
1 Exhibit 2.4 AMENDMENT NO. 1 TO THE RECAPITALIZATION AGREEMENT AMENDMENT NO. 1, dated as of April 23, 1998 (this "Amendment"), to the Recapitalization Agreement, dated as of March 6, 1998 (the "Agreement"), among ECCA Merger Corp., a Delaware...The Recapitalization Agreement • June 10th, 1998 • Eye Care Centers of America Inc • Retail-retail stores, nec
AMENDMENT NO. 1 TO THE RECAPITALIZATION AGREEMENT dated as of June 1, 2007 BETWEEN GLOBAL CROSSING LIMITED AND STT CROSSING LTD.The Recapitalization Agreement • June 7th, 2007 • Global Crossing LTD • Telephone communications (no radiotelephone) • New York
This AMENDMENT NO.1 TO THE RECAPITALIZATION AGREEMENT (this “Amendment”) is made and entered into as of June 1, 2007 (the “Effective Date”), by and among Global Crossing Limited, a company organized under the laws of Bermuda (“Global Crossing”) and STT Crossing Ltd., a company organized under the laws of Mauritius (“STT Crossing”).
Amendment No. 1 to the Recapitalization AgreementThe Recapitalization Agreement • August 6th, 2008 • Abiomed Inc • Surgical & medical instruments & apparatus
This Amendment No. 1 to the Recapitalization Agreement is dated as of July 31, 2008 (this “Amendment No. 1”), by and among (i) World Heart Corporation (the “Company”), (ii) World Heart Inc. (“WHI”), (iii) ABIOMED, Inc. (“Abiomed”), (iv) Venrock Partners V, L.P., Venrock Associates V, L.P. and Venrock Entrepreneurs Fund V, L.P. (collectively, “Venrock”), (v) Special Situations Fund III QP, L.P., Special Situations Cayman Fund, L.P., Special Situations Private Equity Fund, L.P. and Special Situations Life Sciences Fund, L.P. (collectively, “SSF”) and (vi) New Leaf Ventures II, L.P. (“New Leaf”). Capitalized terms used herein and not otherwise defined have the meanings given them in the Recapitalization Agreement.
Amendment No. 1 to the Recapitalization AgreementThe Recapitalization Agreement • August 8th, 2008 • New Leaf Ventures II, L.P. • Electromedical & electrotherapeutic apparatus
This Amendment No. 1 to the Recapitalization Agreement is dated as of July 31, 2008 (this “Amendment No. 1”), by and among (i) World Heart Corporation (the “Company”), (ii) World Heart Inc. (“WHI”), (iii) ABIOMED, Inc. (“Abiomed”), (iv) Venrock Partners V, L.P., Venrock Associates V, L.P. and Venrock Entrepreneurs Fund V, L.P. (collectively, “Venrock”), (v) Special Situations Fund III QP, L.P., Special Situations Cayman Fund, L.P., Special Situations Private Equity Fund, L.P. and Special Situations Life Sciences Fund, L.P. (collectively, “SSF”) and (vi) New Leaf Ventures II, L.P. (“New Leaf”). Capitalized terms used herein and not otherwise defined have the meanings given them in the Recapitalization Agreement.
